ArcherDX receives approval for Archer®MET Companion Diagnostic in advanced non-small cell lung cancer in Japan

ArcherDX receives approval for Archer®MET Companion Diagnostic in advanced non-small cell lung cancer in Japan

BOULDER -- ArcherDX, Inc. announced its ArcherMET companion diagnostic (CDx) has been approved by the Japanese Ministry of Health, Labour and Welfare and the Pharmaceutical Medical Devices Agency... Read More

Wednesday March 25, 2020 0 comments Tags: Boulder, ArcherDx, ArcherMET, Jason Myers